# Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions

Study · id `cardio:ct-nct04242134` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04242134](<https://clinicaltrials.gov/study/NCT04242134>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04242134

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 784 participants.

## Technical summary

Registry record NCT04242134. Randomized; single masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2024-06-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 784 participants (enrolled count; ClinicalTrials.gov record NCT04242134, source copy `cardio:ctgov-nct04242134-2025-12-15`, retrieved 2026-10-26)
- Started: 2020-09-08 (actual) (ClinicalTrials.gov record NCT04242134, source copy `cardio:ctgov-nct04242134-2025-12-15`, retrieved 2026-10-26)
- Primary completion: 2024-06-27 (actual) (ClinicalTrials.gov record NCT04242134, source copy `cardio:ctgov-nct04242134-2025-12-15`, retrieved 2026-10-26)
- Completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT04242134, source copy `cardio:ctgov-nct04242134-2025-12-15`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04242134, source copy `cardio:ctgov-nct04242134-2025-12-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04242134-2025-12-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
- Acronym: DCB-BIF
- Condition: Coronary Artery Disease
- Intervention (Device): Drug-coating balloon
- Lead sponsor: Nanjing First Hospital, Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Nanjing First Hospital, Nanjing Medical University (`cardio:org-nanjing-first-hospital-nanjing-medical-university`)

## Provenance

Content hash: 33db7bf37e1188548f7d799d725b333ae5d9ba9aac4b0793c2fff886bbf990e9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
